This website is intended for US healthcare professionals only.
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Clinical Trials
Congresses
Publications
Disease State Information & Resources
Hereditary Angioedema (HAE)
Netherton Syndrome (NS)
Diabetic Macular Edema (DME)
Complement-Mediated Diseases
Contact Us
Contact BioCryst
Submit an Inquiry
Request a Grant or Sponsorship
Expanded-Access Program
Search Medical Information
Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Oral Once-Daily Berotralstat for the Prevention of Hereditary Angioedema Attacks: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Informed Decision-Making in Hereditary Angioedema Prophylaxis
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
The current situation of hereditary angioedema patients in Germany: results of an online survey
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Patient and Caregiver Perspectives on Oral Transition in the Emerging Hereditary Angioedema Treatment Landscape
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Population Pharmacokinetic Modeling and Simulations of Berotralstat for Prophylactic Treatment of Attacks of Hereditary Angioedema
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Long-Term Safety and Effectiveness of Berotralstat for Hereditary Angioedema: The Open-Label APeX-S Study
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
A Case of Normal C1 Esterase Inhibitor Hereditary Angioedema Successfully Treated with Berotralstat
View Article
biocryst
February 12, 2025
Hereditary Angioedema (HAE)
Previous Page
1
2
3
4
5
6
Next Page
